Aspirin Loading in ACS Patients Already on Aspirin 75 mg Daily
Yes, administer an immediate loading dose of 162–325 mg non-enteric-coated aspirin to every patient presenting with acute coronary syndrome, regardless of whether they are already taking aspirin 75 mg daily. 1
Rationale for Loading Despite Chronic Aspirin Use
Patients already on chronic aspirin therapy should receive 75–325 mg aspirin before any PCI procedure is performed, which applies to the ACS setting where urgent intervention is anticipated. 2
The loading dose ensures rapid and complete inhibition of thromboxane A₂-dependent platelet aggregation in acute thrombotic situations, which is critical during the hyperacute phase of ACS when platelet activation is maximal. 3
Chew the aspirin tablet immediately to achieve the fastest antiplatelet effect through buccal absorption, avoiding enteric-coated formulations that significantly delay absorption when rapid action is essential. 1, 4
Evidence-Based Dosing Protocol
Give 162–325 mg as the loading dose (both doses fall within guideline-recommended ranges and achieve near-total thromboxane inhibition). 1, 4
After the loading dose, transition to maintenance aspirin 75–100 mg daily rather than higher doses, which increases bleeding risk without improving efficacy. 1, 5
In the CURE trial, patients with ACS benefited from clopidogrel addition regardless of aspirin dose, but bleeding risk increased progressively with aspirin doses ≥200 mg daily (adjusted hazard ratio 1.7 for major bleeding with high-dose versus low-dose aspirin). 5
Practical Implementation
Administer the loading dose as soon as ACS is recognized, ideally in the pre-hospital or emergency department setting before any delay occurs. 1, 4
Use non-enteric-coated, chewable aspirin to maximize speed of platelet inhibition; enteric-coated formulations should be avoided in acute settings. 1, 4
If oral administration is impossible, rectal aspirin 325 mg is an acceptable alternative route. 1
Common Pitfalls to Avoid
Do not skip the loading dose simply because the patient is already on aspirin 75 mg daily—chronic low-dose aspirin does not provide the immediate, maximal platelet inhibition required during acute coronary thrombosis. 2, 1
Do not delay aspirin administration while awaiting physician consultation or diagnostic confirmation; each minute of delay reduces mortality benefit in acute MI. 4
Do not use enteric-coated aspirin for the acute loading dose, as it delays absorption when rapid action is critical. 1, 4
Do not continue high-dose aspirin (≥160 mg) for maintenance therapy—switch to 75–100 mg daily after the first 24 hours to minimize bleeding complications. 1, 5